Li Q - Search Results

1

A nano-platform combats the "attack" and "defense" of cytoskeleton to block cascading tumor metastasis.

Tao J, Yao Y, Huang M, Wu J, Lyu J, Li Q, Li L, Huang Y, Zhou Z. Tao J, et al. Among authors: li l, li q. J Control Release. 2024 Mar;367:572-586. doi: 10.1016/j.jconrel.2024.01.069. Epub 2024 Feb 5. J Control Release. 2024. PMID: 38301926

2

A novel mitochondrial targeted hybrid peptide modified HPMA copolymers for breast cancer metastasis suppression.

Li Q, Yang J, Chen C, Lin X, Zhou M, Zhou Z, Huang Y. Li Q, et al. J Control Release. 2020 Sep 10;325:38-51. doi: 10.1016/j.jconrel.2020.06.010. Epub 2020 Jun 26. J Control Release. 2020. PMID: 32598957

3

Enhanced cellular uptake by non-endocytic pathway for tumor therapy.

Liu Y , Li Q , Xiong X , Huang Y , Zhou Z . Liu Y , et al. Among authors: li q. J Mater Chem B. 2018 Dec 7;6(45):7411-7419. doi: 10.1039/c8tb01698d. Epub 2018 Oct 22. J Mater Chem B. 2018. PMID: 32254742

4

Combination of mitochondria targeting doxorubicin with Bcl-2 function-converting peptide NuBCP-9 for synergistic breast cancer metastasis inhibition.

Yang J, Li Q, Zhou R, Zhou M, Lin X, Xiang Y, Xie D, Huang Y, Zhou Z. Yang J, et al. Among authors: li q. J Mater Chem B. 2021 Feb 7;9(5):1336-1350. doi: 10.1039/d0tb02564j. Epub 2021 Jan 14. J Mater Chem B. 2021. PMID: 33443508

5

Targeting the Opening of Mitochondrial Permeability Transition Pores Potentiates Nanoparticle Drug Delivery and Mitigates Cancer Metastasis.

Lin X, Li L, Li S, Li Q, Xie D, Zhou M, Huang Y. Lin X, et al. Among authors: li s, li l, li q. Adv Sci (Weinh). 2020 Dec 31;8(4):2002834. doi: 10.1002/advs.202002834. eCollection 2021 Feb. Adv Sci (Weinh). 2020. PMID: 33643797 Free PMC article.

6

Concurrent impairment of nucleus and mitochondria for synergistic inhibition of cancer metastasis.

Yang J, Li Q, Zhou M, Li X, Huang Y, Yang N, Zhou Z. Yang J, et al. Among authors: li x, li q. Int J Pharm. 2021 Oct 25;608:121077. doi: 10.1016/j.ijpharm.2021.121077. Epub 2021 Sep 4. Int J Pharm. 2021. PMID: 34487811

7

A liposome-based combination strategy using doxorubicin and a PI3K inhibitor efficiently inhibits pre-metastatic initiation by acting on both tumor cells and tumor-associated macrophages.

Luo C, Zhou M, Chen C, Li S, Li Q, Huang Y, Zhou Z. Luo C, et al. Among authors: li s, li q. Nanoscale. 2022 Mar 24;14(12):4573-4587. doi: 10.1039/d1nr08215a. Nanoscale. 2022. PMID: 35253829

8

Stimuli-responsive nano vehicle enhances cancer immunotherapy by coordinating mitochondria-targeted immunogenic cell death and PD-L1 blockade.

Li Q, Chen C, Kong J, Li L, Li J, Huang Y. Li Q, et al. Among authors: li j, li l. Acta Pharm Sin B. 2022 May;12(5):2533-2549. doi: 10.1016/j.apsb.2021.11.005. Epub 2021 Dec 29. Acta Pharm Sin B. 2022. PMID: 35646521 Free PMC article.

9

Mitochondria-targeting and cell-penetrating peptides-co-modified HPMA copolymers for enhancing therapeutic efficacy of α-tocopheryl succinate.

Liu Y , Li Q , Xiong X , Huang Y , Zhou Z . Liu Y , et al. Among authors: li q. J Mater Chem B. 2018 Dec 14;6(46):7674-7683. doi: 10.1039/c8tb02621a. Epub 2018 Nov 6. J Mater Chem B. 2018. PMID: 32254889

10

Improved mitochondrial targeting effect of HPMA copolymer by SS20 peptide mediation and nonendocytosis pathway.

Liu Y, Li Q, Xiong X, Zhou Z. Liu Y, et al. Among authors: li q. J Pept Sci. 2019 Feb;25(2):e3144. doi: 10.1002/psc.3144. Epub 2018 Dec 27. J Pept Sci. 2019. PMID: 30588703

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

66,115 results

Search Page

Filters